These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

63 related items for PubMed ID: 8577632

  • 21. Economic analysis of oral and topical therapies for onychomycosis of the toenails and fingernails.
    Casciano J, Amaya K, Doyle J, Arikian S, Shear N, Haspel M, Kahler K.
    Manag Care; 2003 Mar; 12(3):47-54. PubMed ID: 12685377
    [Abstract] [Full Text] [Related]

  • 22. Treatment in Kenyan rural health facilities: projected drug costs using the WHO-UNICEF integrated management of childhood illness (IMCI) guidelines.
    Boulanger LL, Lee LA, Odhacha A.
    Bull World Health Organ; 1999 Mar; 77(10):852-8. PubMed ID: 10593034
    [Abstract] [Full Text] [Related]

  • 23. Pharmacoeconomic analysis of selected antibiotics in lower respiratory tract infection.
    Quenzer RW, Pettit KG, Arnold RJ, Kaniecki DJ.
    Am J Manag Care; 1997 Jul; 3(7):1027-36. PubMed ID: 10173367
    [Abstract] [Full Text] [Related]

  • 24. [Analysis of the cost-effectiveness relationship in the empirical treatment in patients with infections of the lower respiratory tract acquired in the community].
    Bertrán MJ, Trilla A, Codina C, Carné X, Ribas J, Asenjo MA.
    Enferm Infecc Microbiol Clin; 2000 Nov; 18(9):445-51. PubMed ID: 11149168
    [Abstract] [Full Text] [Related]

  • 25. [Evaluation of the medical value of a drug. A necessity for the Transparency Commission].
    Avouac B.
    Therapie; 1992 Nov; 47(1):9-16. PubMed ID: 1523604
    [Abstract] [Full Text] [Related]

  • 26. Application of decision analysis to drug selection for formulary addition.
    Kresel JJ, Hutchings HC, MacKay DN, Weinstein MC, Read JL, Taylor-Halvorsen K, Ashley H.
    Hosp Formul; 1987 Jul; 22(7):658-63, 673, 676. PubMed ID: 10282682
    [Abstract] [Full Text] [Related]

  • 27. Potential economic effets of a brand standardization policy in a 1000-bed hospital.
    Swift RG, Ryan MR.
    Am J Hosp Pharm; 1975 Dec; 32(12):1242-50. PubMed ID: 1211397
    [Abstract] [Full Text] [Related]

  • 28. [Collection and elaboration of the economic information necessary for calculating the costs of therapeutic decisions].
    Viens-Bitker C, Leclercq B.
    Arch Mal Coeur Vaiss; 1989 Oct; 82 Spec No 3():49-53. PubMed ID: 2512888
    [Abstract] [Full Text] [Related]

  • 29. The managed care approach to placing a drug on formulary.
    Bronson DM.
    Cutis; 2004 May; 73(5 Suppl):33. PubMed ID: 15182167
    [Abstract] [Full Text] [Related]

  • 30. Formulary decisions: then and now.
    Boucher BA.
    Pharmacotherapy; 2010 Jun; 30(6 Pt 2):35S-41S. PubMed ID: 20500042
    [Abstract] [Full Text] [Related]

  • 31. Decision analysis in formulary decision making.
    Schechter CB.
    Pharmacoeconomics; 1993 Jun; 3(6):454-61. PubMed ID: 10146880
    [Abstract] [Full Text] [Related]

  • 32. Establishing value in managed care: cost-effectiveness or budgetary impact?
    Clouse J.
    J Allergy Clin Immunol; 2002 May; 109(5 Suppl):S511-3. PubMed ID: 11994723
    [Abstract] [Full Text] [Related]

  • 33. Formulary decision-making about cephalosporins with similar therapeutic uses.
    Mabe DM.
    Am J Health Syst Pharm; 2003 May 15; 60(10 Suppl 1):S12-5. PubMed ID: 12789882
    [Abstract] [Full Text] [Related]

  • 34. A systems model for food purchasing.
    Webster DB, Drogan RA, Wingard RM, Dillard CE.
    J Am Diet Assoc; 1981 Mar 15; 78(3):255-60. PubMed ID: 7217581
    [Abstract] [Full Text] [Related]

  • 35. [Trust-based economics with medicine outcome-based pricing].
    Lhoste F.
    Ann Pharm Fr; 2013 Sep 15; 71(5):279-84. PubMed ID: 24075698
    [Abstract] [Full Text] [Related]

  • 36. The System of Objectified Judgement Analysis (SOJA). A tool in rational drug selection for formulary inclusion.
    Janknegt R, Steenhoek A.
    Drugs; 1997 Apr 15; 53(4):550-62. PubMed ID: 9098659
    [Abstract] [Full Text] [Related]

  • 37. The price function of toxicity.
    Vincent MD, Dranitsaris G.
    Lancet Oncol; 2009 Mar 15; 10(3):299-303. PubMed ID: 19261259
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effect of a highly restrictive formulary on the average prescription cost at a community health center.
    Chiefari DM.
    Am J Health Syst Pharm; 2000 May 01; 57(9):846-7. PubMed ID: 10840524
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.